Premium
The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non‐ST acute coronary syndrome
Author(s) -
FRÉRE C.,
CUISSET T.,
GABORIT B.,
ALESSI M.C.,
HULOT J.S.
Publication year - 2009
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2009.03500.x
Subject(s) - clopidogrel , thienopyridine , p2y12 , cyp2c19 , platelet , pharmacology , ticlopidine , medicine , metabolite , active metabolite , cyp2d6 , platelet activation , acute coronary syndrome , cyp3a4 , cytochrome p450 , aspirin , chemistry , metabolism , myocardial infarction